Abbott Laboratories Retained Earnings (Accumulated Deficit) 2010-2024 | ABT
Abbott Laboratories retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $38.354B, a 5.5% increase year-over-year.
- Abbott Laboratories retained earnings (accumulated deficit) for 2023 were $37.554B, a 6.52% increase from 2022.
- Abbott Laboratories retained earnings (accumulated deficit) for 2022 were $35.257B, a 11.83% increase from 2021.
- Abbott Laboratories retained earnings (accumulated deficit) for 2021 were $31.528B, a 14.12% increase from 2020.